{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:41:17Z","timestamp":1770478877423,"version":"3.49.0"},"reference-count":48,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>OBJECTIVE. The purpose of this study was to assess the health status and school-age neurodevelopmental progress of antiretroviral treatment (ARVT)\u2013naive, HIV-infected Ugandan children who had been followed as part of cohorts of children born to HIV-infected and -noninfected mothers between 1989 and 1993.<\/jats:p>\n               <jats:p>METHODS. Twenty-eight children, aged 6 to 12 years, vertically infected with HIV-1 and never treated with ARVT were evaluated in terms of health status, neurologic, and psychometric testing. A randomly selected group of 42 seroreverters and 37 HIV-1 negative children who were age- and gender-matched and who had been followed in the same cohorts were evaluated also. The families studied were homogenous in their socioeconomic status. None of the mothers or children had received ARVT or been exposed to illicit drugs.<\/jats:p>\n               <jats:p>RESULTS. The HIV-infected children showed significantly more evidence of acute malnutrition. They also had more illness, especially parotitis, otitis media, upper respiratory infections, and lymphadenopathy. However, they did not differ significantly in neurologic and cognitive assessments when compared with age- and gender-matched seroreverter and HIV-negative children. They were in the normal range with respect to neurologic and psychometric development measures.<\/jats:p>\n               <jats:p>CONCLUSIONS.These children seem to represent a significant subgroup of HIV-infected child survivors for whom the progress of the disease is less aggressive throughout early life. Given the fact that many infants, especially in developing countries, continue to be born without the benefit of perinatal ARVT, there will likely continue to be many older HIV-infected children in the same situation as those described in this follow-up study. They will not have been recognized as being HIV-infected. It is important that such children be identified and offered access to ARVT and other appropriate support services.<\/jats:p>","DOI":"10.1542\/peds.2004-2699","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T19:23:43Z","timestamp":1141241023000},"page":"729-740","source":"Crossref","is-referenced-by-count":104,"title":["Health, Neurologic, and Cognitive Status of HIV-Infected, Long-Surviving, and Antiretroviral-Naive Ugandan Children"],"prefix":"10.1542","volume":"117","author":[{"given":"Danstan","family":"Bagenda","sequence":"first","affiliation":[{"name":"Makerere University Medical School, Kampala, Uganda"},{"name":"Behavioral and Developmental Pediatrics, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Nassali","sequence":"additional","affiliation":[{"name":"Makerere University Medical School, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Kalyesubula","sequence":"additional","affiliation":[{"name":"Makerere University Medical School, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Sherman","sequence":"additional","affiliation":[{"name":"International Health\/Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Drotar","sequence":"additional","affiliation":[{"name":"International Health\/Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Boivin","sequence":"additional","affiliation":[{"name":"International Health\/Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Psychology, Indiana Wesleyan University, Marion, Indianapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Olness","sequence":"additional","affiliation":[{"name":"International Health\/Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2021120820125918300_R1","doi-asserted-by":"crossref","unstructured":"Drotar D, Olness K, Wiznitzer M, et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics.\u20081997;100(1). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/1\/e5","DOI":"10.1542\/peds.100.1.e5"},{"key":"2021120820125918300_R2","doi-asserted-by":"crossref","unstructured":"Ultmann MH, Diamond GW, Ruff HA, et al. Developmental abnormalities in children with acquired immunodeficiency syndrome (AIDS): a follow-up study. Int J Neurosci.\u20081987;32:661\u2013667","DOI":"10.3109\/00207458709043320"},{"key":"2021120820125918300_R3","doi-asserted-by":"crossref","unstructured":"Condini A, Axia G, Cattelan C, et al. Development of language in 18\u201330-month-old HIV-1-infected but not ill children. AIDS.\u20081991;5:735\u2013739","DOI":"10.1097\/00002030-199106000-00014"},{"key":"2021120820125918300_R4","doi-asserted-by":"crossref","unstructured":"Levenson RL Jr, Mellins CA, Zawadzki R, Kairam R, Stein Z. Cognitive assessment of human immunodeficiency virus-exposed children. Am J Dis Child.\u20081992;146:1479\u20131483","DOI":"10.1001\/archpedi.1992.02160240089028"},{"key":"2021120820125918300_R5","doi-asserted-by":"crossref","unstructured":"Boivin MJ, Green SDR, Davies AG, Giordani B, Mokili JKL, Cutting WAM. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol.\u20081995;14:13\u201321","DOI":"10.1037\/0278-6133.14.1.13"},{"key":"2021120820125918300_R6","doi-asserted-by":"crossref","unstructured":"Diamond GW, Gurdin P, Wiznia AA, Belman AL, Rubinstein A, Cohen HJ. Effects of congenital HIV infection on neurodevelopmental status of babies in foster care. Dev Med Child Neurol.\u20081990;32:999\u20131005","DOI":"10.1111\/j.1469-8749.1990.tb08123.x"},{"key":"2021120820125918300_R7","unstructured":"Bisiacchi PS, Suppiej A, Laverda A. Neuropsychological evaluation of neurologically asymptomatic HIV infected children. Brain Cogn.\u20082000;43:49\u201352"},{"key":"2021120820125918300_R8","doi-asserted-by":"crossref","unstructured":"Bruck I, Tahan TT, da-Cruz CR, et al. Developmental milestones of vertically HIV infected and seroreverter children. Arq Neuropsiquiatr.\u20082001;59:691\u2013695","DOI":"10.1590\/S0004-282X2001000500007"},{"key":"2021120820125918300_R9","unstructured":"Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A. Effects of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics.\u20081994;94:883\u2013891"},{"key":"2021120820125918300_R10","doi-asserted-by":"crossref","unstructured":"Price DB, Inglese CM, Jacobs J, et al. Pediatric AIDS: neuroradiologic and neurodevelopmental findings. Pediatr Radiol.\u20081988;18:445\u2013448","DOI":"10.1007\/BF00974074"},{"key":"2021120820125918300_R11","doi-asserted-by":"crossref","unstructured":"Belman AL, Diamond G, Dickson D, et al. Pediatric acquired immunodeficiency syndrome: neurologic syndromes. Am J Dis Child.\u20081988;142:29\u201335","DOI":"10.1001\/archpedi.1988.02150010039017"},{"key":"2021120820125918300_R12","doi-asserted-by":"crossref","unstructured":"Mitchell W. Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Rev.\u20082001;7:211\u2013216","DOI":"10.1002\/mrdd.1029"},{"key":"2021120820125918300_R13","unstructured":"Brouwers P, Wolters P, Civitello L. Central nervous system manifestations and assessment. In: Pizzo PA, Wilfert CMn, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999:293\u2013308"},{"key":"2021120820125918300_R14","doi-asserted-by":"crossref","unstructured":"Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics.\u20081999;104(5). Available at: www.pediatrics.org\/cgi\/content\/full\/104\/5\/e56","DOI":"10.1542\/peds.104.5.e56"},{"key":"2021120820125918300_R15","doi-asserted-by":"crossref","unstructured":"Zijenah L, Mbizvo MT, Kasule J, et al. Mortality in the first 2 years among infants born to human immunodeficiency virus-infected women in Harare, Zimbabwe. J Infect Dis.\u20081998;178:109\u2013113","DOI":"10.1086\/515604"},{"key":"2021120820125918300_R16","doi-asserted-by":"crossref","unstructured":"Crampin AC, Floyd S, Glynn JR, et al. The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi. AIDS.\u20082003;17:389\u2013397","DOI":"10.1097\/00002030-200302140-00013"},{"key":"2021120820125918300_R17","doi-asserted-by":"crossref","unstructured":"Ryder RW, Nsuami M, Nsa W, et al. Morality in HIV-1 seropositive women, their spouses, and their newly born children during 36 months of follow-up in Kinshasha, Zaire. AIDS.\u20081994;8:667\u2013672","DOI":"10.1097\/00002030-199405000-00014"},{"key":"2021120820125918300_R18","unstructured":"Drotar D, Olness K, Wiznitzer M, et al. Neurodevelopmental outcomes of Ugandan infants with HIV infection, an application of growth curve analysis. Health Psychol.\u20081999;19:1\u20138"},{"key":"2021120820125918300_R19","doi-asserted-by":"crossref","unstructured":"Kalyesubula I, Musoke-Mudido P, Marum L, Bagenda D, Ndugwa C, Olness K. Effects of malaria infection in HIV-1 infected Ugandan children. Pediatr Infect Dis J.\u20081997;16:876\u2013881","DOI":"10.1097\/00006454-199709000-00011"},{"key":"2021120820125918300_R20","doi-asserted-by":"crossref","unstructured":"Peterson NJ, Drotar D, Olness K, Guay L, Kiziri-Mayengo R. The relationship of maternal and child HIV infection to security of attachment among Ugandan infants. Child Psychiatry Hum Dev.\u20082001;32:3\u201317","DOI":"10.1023\/A:1017581412328"},{"key":"2021120820125918300_R21","doi-asserted-by":"crossref","unstructured":"Mandalakas A, Guay L, Musoke P, Carrol-Pankhurst C, Olness K. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children. Pediatrics.\u20081999;103(2). Available at: www.pediatrics.org\/cgi\/content\/full\/103\/2\/e21","DOI":"10.1542\/peds.103.2.e21"},{"key":"2021120820125918300_R22","unstructured":"Neely M, Kalyesubula I, Bagenda D, Myers C, Olness K. Cord blood chloroquine levels and HIV transmission in Ugandan infants. Afr Health Sci.\u20082003;3:6"},{"key":"2021120820125918300_R23","doi-asserted-by":"crossref","unstructured":"Berhane R, Bagenda D, Marum L, et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics.\u20081997;100(1). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/1\/e7","DOI":"10.1542\/peds.100.1.e7"},{"key":"2021120820125918300_R24","doi-asserted-by":"crossref","unstructured":"Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children: Administration and Scoring Manual. Circle Pines, MN: American Guidance Services Inc; 1983","DOI":"10.1037\/t27677-000"},{"key":"2021120820125918300_R25","doi-asserted-by":"crossref","unstructured":"Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children: Interpretive Manual. Circle Pines, MN: American Guidance Services Inc; 1983","DOI":"10.1037\/t27677-000"},{"key":"2021120820125918300_R26","doi-asserted-by":"crossref","unstructured":"Boivin MJ, Giordani B. Improvements in cognitive performance for school children in Zaire, Africa following an iron supplement and treatment for intestinal parasites. J Pediatr Psychol.\u20081993;18:249\u2013264","DOI":"10.1093\/jpepsy\/18.2.249"},{"key":"2021120820125918300_R27","doi-asserted-by":"crossref","unstructured":"Boivin MJ, Giordani B, Kisoki N, et al. Effects of treatment for intestinal parasites and malaria on the cognitive abilities of school children in Zaire, Africa. Health Psychol.\u20081993;12:220\u2013226","DOI":"10.1037\/0278-6133.12.3.220"},{"key":"2021120820125918300_R28","unstructured":"Marum L, Bagenda D, Guay L. Three year mortality in a cohort of HIV-1 infected and uninfected Ugandan children [abstract]. XIth International Conference on AIDS STD, Vancouver, British Columbia, Canada; July 7\u201312, 1996. Abstract WeB 312"},{"key":"2021120820125918300_R29","unstructured":"World Health Organization. The world health report 2003. Available at: www.who.int\/whr\/2003\/en\/index.html. Accessed December 22, 2005"},{"key":"2021120820125918300_R30","doi-asserted-by":"crossref","unstructured":"Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet.\u20081999;354:795\u2013802","DOI":"10.1016\/S0140-6736(99)07419-X"},{"key":"2021120820125918300_R31","doi-asserted-by":"crossref","unstructured":"Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet.\u20082003;362:859\u2013868","DOI":"10.1016\/S0140-6736(03)14341-3"},{"key":"2021120820125918300_R32","doi-asserted-by":"crossref","unstructured":"The Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra Study): a randomised, double-blind, placebo-controlled trial. Lancet.\u20082002;359:1178\u20131186","DOI":"10.1016\/S0140-6736(02)08214-4"},{"key":"2021120820125918300_R33","doi-asserted-by":"crossref","unstructured":"Diamond GW, Kaufman J, Belman AL, Cohen L, Cohen HJ, Rubinstein A. Characterization of cognitive functioning in a subgroup of children with congenital HIV infection. Arch Clin Neuropsychol.\u20081987;2:245\u2013256","DOI":"10.1093\/arclin\/2.3.245"},{"key":"2021120820125918300_R34","doi-asserted-by":"crossref","unstructured":"Frank E, Foley G, Gilbert M, Kuchuk A. Cognitive functioning in school-age children with human immunodeficiency virus. Percept Mot Skills.\u20081997;85:267\u2013272","DOI":"10.2466\/pms.1997.85.1.267"},{"key":"2021120820125918300_R35","unstructured":"Pulsifer MB, Aylward EH. Human immunodeficiency virus. In: Yeates KO, Ris MD, eds. Pediatric Neuropsychology: Research, Theory, and Practice. New York, NY: Guilford Press; 2000:381\u2013402. The Science and Practice of Neuropsychology: A Guilford Series"},{"key":"2021120820125918300_R36","doi-asserted-by":"crossref","unstructured":"Henry RR, Christensen BK, Coscia JM, Cohen F, Moore E. Relationship between cognitive and immune functioning in children born to HIV-1 seropositive women. Dev Neurospsychol.\u20081996;12:283\u2013298","DOI":"10.1080\/87565649609540653"},{"key":"2021120820125918300_R37","doi-asserted-by":"crossref","unstructured":"Rausch DM, Stover ES. Neuroscience research in AIDS. Prog Neuropsychopharmacol Biol Psychiatry.\u20082001;25:231\u2013257","DOI":"10.1016\/S0278-5846(00)00154-8"},{"key":"2021120820125918300_R38","doi-asserted-by":"crossref","unstructured":"Tardieu M, Mayaux M, Seibel N, et al. Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr.\u20081995;126:375\u2013379","DOI":"10.1016\/S0022-3476(95)70451-5"},{"key":"2021120820125918300_R39","doi-asserted-by":"crossref","unstructured":"Blanchette N, Smith ML, Fernandes-Penney A, King S, Read S. Cognitive and motor development in children with vertically transmitted HIV infections. Brain Cogn.\u20082001;46:50\u201353","DOI":"10.1016\/S0278-2626(01)80032-4"},{"key":"2021120820125918300_R40","doi-asserted-by":"crossref","unstructured":"Fishkin P, Armstrong F, Routh D, et al. Brief report: relationship between HIV infection and WPPSI-R performance in preschool-age children. J Pediatr Psychol.\u20082000;25:347\u2013351","DOI":"10.1093\/jpepsy\/25.5.347"},{"key":"2021120820125918300_R41","doi-asserted-by":"crossref","unstructured":"Smith R, Malee K, Charurat M, et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group. Pediatr Infect Dis J.\u20082000;19:862\u2013871","DOI":"10.1097\/00006454-200009000-00010"},{"key":"2021120820125918300_R42","doi-asserted-by":"crossref","unstructured":"Pollack H, Kuchuk A, Cowan L, et al. Neurodevelopment, growth, and viral load in HIV-infected infants. Brain Behav Immunol.\u20081996;10:298\u2013312","DOI":"10.1006\/brbi.1996.0026"},{"key":"2021120820125918300_R43","doi-asserted-by":"crossref","unstructured":"Fair C, Spencer E, Wiener L, Riekert K. Healthy children in families affected by AIDS: epidemiological and psychosocial considerations. Child Adolesc Social Work J.\u20081995;12:165\u2013181","DOI":"10.1007\/BF01876770"},{"key":"2021120820125918300_R44","doi-asserted-by":"crossref","unstructured":"Kullgren K, Morris MK, Bachanas PJ, Jones J. Prediction of cognitive, adaptive, and behavioral functioning in preschool and school-age children with HIV. Child Health Care.\u20082004;33:241\u2013256","DOI":"10.1207\/s15326888chc3304_1"},{"key":"2021120820125918300_R45","doi-asserted-by":"crossref","unstructured":"Coscia J, Christensen B, Henry R, Wallston K, Radcliffe J, Rutstein R. Effects of home environment, socioeconomic status, and health status on cognitive functioning in children with HIV-1 infection. J Pediatr Psychol.\u20082001;26:321\u2013329","DOI":"10.1093\/jpepsy\/26.6.321"},{"key":"2021120820125918300_R46","doi-asserted-by":"crossref","unstructured":"Mellins C, Levenson R, Zawadzki R, Kairam R, Weston M. Effects of pediatric HIV infection and prenatal drug exposure on mental and psychomotor development. J Pediatr Psychol.\u20081994;19:617\u2013627","DOI":"10.1093\/jpepsy\/19.5.617"},{"key":"2021120820125918300_R47","unstructured":"Foster G, Williamson J. A review of current literature on the impact of HIV\/AIDS on children in sub-Saharan Africa. AIDS.\u20082000;14:S275\u2013S284"},{"key":"2021120820125918300_R48","doi-asserted-by":"crossref","unstructured":"Nozyce M, Hoberman M, Arpadi S, Wiznia A. A 12-month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV-infected inner-city children. AIDS.\u20081994;8:635\u2013639","DOI":"10.1097\/00002030-199405000-00009"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/729\/1069937\/zpe00306000729.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/729\/1069937\/zpe00306000729.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T23:51:13Z","timestamp":1639007473000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/3\/729\/68615\/Health-Neurologic-and-Cognitive-Status-of-HIV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2699","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}